Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 2/20 | 0.42 |
| ▸ | TLK2 | Q86UE8 | 5/20 | 0.42 |
| ▸ | RET | P07949 | 2/20 | 0.39 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1304859 | 0.93 | ALDH1A1 (0.43) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL3130088 | 0.91 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL3130082 | 0.91 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304354 | 0.90 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304351 | 0.90 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304522 | 0.86 | ALDH1A1 (0.58) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304521 | 0.86 | ALDH1A1 (0.58) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304433 | 0.83 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304434 | 0.83 | PIM1 (0.52) | PTPN1PTPN2ALDH1A1DYRK1AMEN1 | |
| SCHEMBL1304322 | 0.83 | RET (0.52) | ALDH1A1DYRK1AMEN1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8053461-B2 | Oxindole derivative | THERAVALUES CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20100076049-A1 | NOVEL OXINDOLE DERIVATIVE | THERAVALUES CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| EP-2130829-A1 | NOVEL HYDROXYINDOLE DERIVATIVE | Theravalues Corporation (JP) | 2009-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076049-A1 | NOVEL OXINDOLE DERIVATIVE | CYP2C9, HDAC10, SIGMAR1 | THRB 2003/4885PTPN1 2819/4885PTPN2 2980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.